SESQUIENT

Peak

fosphenytoin sodium

NDAINTRAVENOUSSOLUTION
Approved
Nov 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Feb 27, 2033
85 months away
Patent Expiry
Feb 27, 2033

Patent Records (5)

Patent #ExpiryTypeUse Code
7635773
Mar 13, 2029
Product
—
8410077
Mar 13, 2029
Product
—
9200088
Mar 13, 2029
Product
—
9750822
Mar 13, 2029
Product
—
9493582
Feb 27, 2033
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers